Rising cases of organ failure and the requirement of organ transplantation are the major factors
driving the growth of immunosuppressant drugs market. According to the data published by ONT-
WHO Global Observatory On donation and Transplantation, in 2014, around 119,873 organs were
transplanted globally and an increase of 1.8% was observed from 2013. Advancements in tissue
engineering and transplantation procedures are fuelling the growth of immunosuppressant drugs
market. The increase in rate of autoimmune diseases is also one of the important factors
contributing to the growth of immunosuppressant drugs market. According to the American
Autoimmune Related Disease Association (AARDA), in 2016, there were 50 million people
suffering from autoimmune diseases in the United States. Immunosuppressant drugs have proven to
be effective for the treatment of autoimmune diseases.
Proven efficiency of kidney transplant for end-stage renal diseases to propel market demand
The global immunosuppressant drugs market is segmented by application, drug type, dosage type,
end users, and by region.
On the basis of application, the global immunosuppressant drugs market is segmented into;
•Autoimmune diseases
•Organ transplant
•Kidney transplant
•Liver transplant
•Heart transplant
•Intestine transplant
•Others
On the basis of drug type, the global immunosuppressant drugs market is segmented into;
•Calcineurin inhibitors
•Antibodies
•Corticosteroids
•Antiproliferative agents
•mTOR inhibitors
•Others
On the basis of dosage type, the global immunosuppressant drugs market is segmented into;
•Tablets
•Liquid
•Injectable
On the basis of end user, the global immunosuppressant drugs market is segmented into;
•Hospitals